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Abstract
Background: Low back pain (LBP) and pelvic girdle pain (PGP) during pregnancy are common and often accepted
as a ‘normal’ part of pregnancy. Many women receive little in the way of treatment, and yet pain interferes with
sleep, daily activities and work and leads to increasing requests for induction of labour or elective caesarean
section. The aim of this study was to assess the feasibility of a full RCT evaluating the benefit of acupuncture for
pregnancy-related back pain.
Methods: This study is a single-centre, three-arm pilot RCT in one large maternity unit and associated antenatal
and physiotherapy clinics. Women were eligible if they had pregnancy-related LBP with or without PGP. Exclusions
included a history of miscarriage, high risk of early labour or pre-eclampsia, PGP only and previous acupuncture.
Interventions were standard care (SC): a self-management booklet with physiotherapy if needed. SC+TA: the booklet
and physiotherapy comprising true (penetrating) acupuncture, advice and exercise. SC+NPA: the booklet and
physiotherapy comprising non-penetrating acupuncture, advice and exercise. Remote telephone randomisation
used a 1:1:1 allocation ratio stratified by gestational weeks. Three measures of pain/function were compared to
inform the primary outcome measure in a full RCT: the Pelvic Girdle Questionnaire (PGQ), Oswestry Disability
Index (ODI) and 11-point 0–10 numerical rating scale for pain. Analysis focused on process evaluation of recruitment,
retention, descriptive information on outcomes, adherence to treatment, occurrence of adverse events and impact of
physiotherapist training.
Results: One hundred twenty-five women were randomised (45% of those eligible) between April and October 2013;
73% (n = 91) provided 8-week follow-up data. Three of six recruitment methods accounted for 82% of total uptake:
screening questionnaire at the 20-week scan, community midwives issuing study cards, and self-referral following local
awareness initiatives. Physiotherapists’ self-confidence on managing pregnancy-related LBP improved post training. The
PGQ is suitable as the primary outcome in a full trial. The average number of treatment sessions in both SC+TA
and SC+NPA was six (in line with treatment protocols). No serious adverse events attributable to the trial treatments
were reported.
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Conclusions: A full RCT is feasible and would provide evidence about the effectiveness of acupuncture and inform
treatment choices for women with pregnancy-related LBP.
Trial registration: ISRCTN49955124
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Background
Pregnancy-related back pain
Low back pain (LBP) and pelvic girdle pain (PGP)
during pregnancy are common. Whilst they can occur
separately, many women experience both. Prevalence
estimates suggest between 45 and 75% of women
experience LBP at some stage during their pregnancy
[1, 2] and up to 70% of women experience PGP by
late pregnancy [3–5]. LBP, with or without PGP, is re-
ferred to as pregnancy-related LBP throughout this
paper. Studies have shown that women with
pregnancy-related LBP have lower quality of life com-
pared with non-pregnant healthy women [6], and re-
ports suggest that 20 to 23% of women take sick leave
because of their pain [2]. Pregnancy-related LBP in-
creases with advancing pregnancy, is usually worse at
night and interferes with sleep, daily activities and
work [4]. Indeed, an increasing number of affected
women request induction of labour or elective caesar-
ean section before the recommended 39th week of
gestation [7].
Current clinical management
Pregnancy-related LBP is commonly accepted as a
‘normal’ part of pregnancy [2, 7], and women are en-
couraged to believe that their pain is temporary and self-
limiting which may not always be the case. Women with
pregnancy-related LBP most often report problems to
their midwife, but few receive active treatment for the
condition. In an Australian study, 71% reported their pain
to their maternity carer, but only 25% received any treat-
ment [2].
Most women with pain are advised about self-
management strategies [4]; however, some access a
range of treatments, including physiotherapy-led
exercise, manual therapy, transcutaneous electrical
nerve stimulation (TENS), safe pharmacological op-
tions (mostly paracetamol), and much less com-
monly, epidural injections [2, 4, 7]. In the UK
National Health Service (NHS), management varies
across services and geographical regions. Most
women are not referred from their midwives or GPs
to other health professionals, such as physiothera-
pists, for treatment. Where they are offered physiotherapy,
some are offered one-off educational classes focusing on
self-management advice and others are offered courses of
individualised treatment [8].
Acupuncture
Acupuncture is commonly used for musculoskeletal
problems and is recommended within UK national
guidelines for the management of persistent non-specific
LBP [9]. A small number of studies have evaluated acu-
puncture for pregnancy-related LBP, which have been
summarised in two systematic reviews [4, 10] concluding
promising but limited evidence for its use and highlight
the need for further high quality trials.
This paper reports a pilot randomised controlled
trial (RCT) to test the feasibility of a future, full
trial to evaluate the effectiveness of adding acupunc-
ture to standard care (SC) for pregnancy-related
LBP. In order to inform the interventions and
methods of the pilot RCT, we previously investi-
gated (i) current UK physiotherapy management of
pregnancy-related LBP [8], (ii) the views of physio-
therapists about using acupuncture for pregnancy-
related LBP [11] and (iii) the views of women with
pregnancy-related LBP and midwives about a RCT,
including recruitment and consent procedures and
safety concerns [12].
The specific objectives of the EASE Back pilot trial
were to:
 Test the trial procedures, training programme
for health care professionals, interventions
and outcome measures in women with
pregnancy-related LBP.
 Provide data on likely recruitment and follow-up
rates for a main trial plus completion rates on
key outcomes and an estimate of the standard
deviation for the outcome in order to inform
the sample size requirements of a full trial.
Specific success criteria for progression to a full trial
were not specified a priori, but the findings were
discussed with both the Trial Steering Committee and
at a multi-disciplinary consensus meeting which in-
cluded key local and international experts, health pro-
fessionals and patients who agreed a full trial was
feasible.
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Methods
The EASE Back pilot trial is reported in line with the
CONSORT [13] and STRICTA guidance [14].
Trial design and setting
This pilot trial was a single-centre, three-arm parallel pilot
RCT based in one large maternity unit and associated ante-
natal and physiotherapy clinics in Staffordshire, England.
Recruitment lasted 27 weeks from April to October 2013,
and data were collected at baseline (pre-randomisation)
and at 8 weeks post randomisation. Ethical approval
was granted by NRES Committee West Midlands—
Staffordshire (reference 13/WM/00). The EASE Back
pilot trial is registered on the current controlled trials
database ISRCTN49955124.
Participants
Women were eligible for participation in the pilot trial
if they met the following criteria: had pregnancy-related
LBP defined as self-reported pain in the lumbar area
(between the 12th rib and the gluteal fold) with or
without PGP; under the care of participating NHS sites;
aged 18 years and over; between 13 to 31 weeks gesta-
tion (to increase the likelihood that women had time to
receive the intervention if they were randomised to SC
plus acupuncture and still receive their 8-week follow-
up questionnaire before birth); naïve to acupuncture
treatment and able to read and communicate in English
(to provide full informed consent and to complete the
baseline and outcome assessments).
Exclusion criteria were women who had ever received
any form of acupuncture previously for any health prob-
lem; were at high risk of miscarriage (previously had recur-
rent miscarriage defined as three or more, abnormalities in
the cervix deemed to increase risk of miscarriage, antipho-
spholipid syndrome, lupus anticoagulant); were at high risk
of pre-term labour (previous history of giving birth before
37 weeks gestation, multiple pregnancies, polyhydramnios,
pre-term ruptured membranes, history of surgery to the
uterine cervix); had diagnosed pre-eclampsia; had a
previous history of surgery to the spine or the pelvis;
presence of a contra-indication to any of the treatment
options (coagulation problems, haemophilia or bleeding
disorders, were at increased risk of infection such as
skin infections or loss of skin integrity from burns or
ulcerations at the site of needling or those with a high
needle phobia); had pain in the anterior pelvic girdle region
only; and diagnosed with a current urinary tract infection.
These criteria ensured that participants had pregnancy-
related LBP with no significant risk factors or contra-
indications to acupuncture and hence comparable to
those likely to receive these interventions should a full
trial demonstrate clinical and cost-effectiveness.
Identification and recruitment
Six methods of identifying and recruiting women to the
pilot trial were tested in order to establish the most
successful strategies for a future full trial:
Method 1: women were identified in routine antenatal
clinics by research midwives who determined eligibility,
gained consent, conducted baseline assessments and
randomisation.
Method 2: screening questionnaire handed to all
women at the 20-week routine ultrasound scan
appointment.
Method 3: research midwives screened referrals to
the hospital women’s health physiotherapy service.
Method 4: research midwives identified potentially
eligible women in antenatal clinics, invited them to
consider taking part and gave them an EASE Back
study card with contact details for the study
administrator.
Method 5: community midwives, obstetricians and GPs
identified potentially eligible women, invited them to
consider taking part and gave them an EASE Back
study card with contact details for the study
administrator.
Method 6: self-referral where women with pregnancy-
related LBP who became aware of the pilot trial
through a local awareness-raising campaign could
directly telephone the EASE Back study administrator.
Awareness raising was achieved through study flyers
included in standard maternity booking packs and in
the 20-week ultrasound scan appointment information,
a study-specific website, study flyers and posters
displayed in local GP practices, children’s centres
and the hospital maternity and women’s health
departments. In addition the pilot trial was promoted
through local radio including one-off, free, radio
interviews about the trial and 3 days of continuous
and professionally produced radio infomercials on a
local commercial radio station. A local newspaper also
ran a free two-page spread and paid advertisements
about the study were placed on local buses.
With the exception of method 1, when women con-
tacted the study administrator, a brief initial eligibility
check was undertaken over the telephone. Women who
were initially eligible were posted study information
(letter of invitation, patient information leaflet) and
subsequently contacted by a research midwife or re-
search nurse to complete more detailed eligibility
checking. Eligible women who were interested in taking
part proceeded to a face-to-face appointment with a
research midwife or research nurse for confirmation of
eligibility, informed consent, baseline assessment and
randomisation.
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Randomisation
Eligible women who gave written informed consent to
participate were randomised in a 1:1:1 ratio to one of
the three treatment arms using randomly varying
blocks (sizes 3 and 6) and stratified by gestational
weeks (dichotomised to less than or at least 24 weeks).
Participants were randomised using remote telephone
randomisation provided by a registered Clinical Trials
Unit (CTU registration number 36).
A research midwife or research nurse telephoned the
CTU administrator who conducted the concealed ran-
domisation process and directly informed the partici-
pant about their treatment allocation, in writing. To
maintain blinding of participants to the type of acu-
puncture (true or non-penetrating), treatment alloca-
tion letters described the interventions as ‘usual care’
or ‘usual care plus acupuncture’.
Sample size
In line with pilot trial recommendations [15], EASE
Back did not specify a primary outcome nor was a power
calculation conducted. The sample size was based on
the number of births per year at the participating mater-
nity centre and estimates of the proportion of women
likely to be eligible and consent to participate. The
maternity service oversaw approximately 6100 births per
year, and we estimated that between 50–66% would self-
report back pain at some point in their pregnancy and at
least 30% would self-report back pain at 13–31 weeks
gestation. Thus, we expected that in the region of 600
women would be eligible over a recruitment period of 4
to 5 months with an estimated 25% recruitment rate. To
allow for some withdrawal and loss to follow-up, we
needed to identify 720 women in order to recruit ap-
proximately 180 women and provide follow-up data on
150 women. As an external pilot trial interim analyses
and stopping rules were not required.
Physiotherapists delivering interventions
Fourteen physiotherapists (physical therapists) delivered
the interventions. All the physiotherapists were employed
in the UK National Health Service (NHS) and had pre-
viously completed postgraduate training in the use of
acupuncture for musculoskeletal pain conditions, in
training programmes that met national and interna-
tional standards. Prior to the trial, 11 used acupuncture
in the management of musculoskeletal pain, including
LBP, but none used acupuncture for back pain in preg-
nant women. Participating physiotherapists attended a
3-day training programme with the study team, which
included education about pregnancy and pregnancy-
related LBP, patient assessment, intervention protocols
for the standard care and acupuncture interventions
and trial procedures. Physiotherapists completed three
questionnaires, before and immediately after the train-
ing programme and at the end of the EASE Back pilot
trial. Self-confidence in assessing and managing preg-
nant women with back pain was assessed using four
items (adapted from [16]) where responses are summed
(after reverse-coding the first item) to give a self-
confidence score (0–20); the higher the score the higher
the confidence. Physiotherapists were also asked to in-
dicate their clinical management of a typical patient
presented as a written patient case vignette. In addition,
following the end of all treatment in the pilot trial,
physiotherapists were invited to a feedback workshop
to gain their views on participation in the pilot trial in
order to inform a future full RCT.
Interventions
Participants were randomised to one of three treatment
arms: standard care, standard care plus true acupuncture
or standard care plus non-penetrating acupuncture.
Standard care (SC): the SC intervention was informed
by the results of our studies undertaken prior to this
pilot trial [8, 11, 12]. SC comprised a high quality and
comprehensive self-management booklet, which was
posted to participants following randomisation. Women
could also access EASE Back physiotherapy care if needed,
consisting of an individualised assessment and two to four
treatment sessions over 6 weeks, with the episode of care
‘left open’ until the end of the pregnancy. Usual physio-
therapy treatments could be used in face-to face physio-
therapy sessions and might include advice, exercise
approaches, heat, massage, manual therapy and issuing of
pelvic supports/belts. Hydrotherapy, group treatments
and acupuncture were not permitted within the protocol
for SC alone. Women were not instructed to avoid other
treatments, but their use of other treatments was moni-
tored through self-report questions in the follow-up
questionnaire.
Standard care plus true acupuncture (SC+TA): the
same self-management booklet was posted to partici-
pants randomised to this arm. In addition, EASE Back
trained physiotherapists delivered true acupuncture. This
consisted of an individualised assessment followed by six
to eight treatment sessions over 6 weeks with the acu-
puncture treatment lasting 20–30 min and manual
stimulation of the needles aimed to elicit and maintain
De Qi needling sensation. Depending on assessment
findings, physiotherapists chose a minimum of 6 and a
maximum of 10 bilateral points (between 12 and 20
points in total) using the principles of Western acupunc-
ture and trigger point acupuncture from the list pre-
sented in Table 1.
Standard care plus non-penetrating acupuncture
(SC+NPA): to control for time and attention with
physiotherapists and non-specific effects of
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acupuncture, a SC+NPA intervention arm was in-
cluded. The non-penetrating needles look exactly like
real needles, but the tip is blunted and the shaft of the
needle slides in the handle, giving an illusion of pene-
tration. The non-penetrating Streitberger needle has
been used successfully in two previous trials of acu-
puncture [17, 18]. The same self-management booklet
was posted to participants randomised to SC+NPA
intervention arm. NPA was delivered by the same EASE
Back trained physiotherapists and consisted of an indivi-
dualised assessment followed by six to eight treatment
sessions over a period of 6 weeks. The non-penetrating
acupuncture was applied bilaterally over four bilateral
points (eights acupuncture points in total) with treat-
ments lasting 20–30 min.
For each participant, physiotherapists recorded full
details of the treatment sessions including number, any
non-attendance, the acupuncture points used, any sensa-
tions reported by participants during acupuncture treat-
ments and any adverse events on case report forms.
These case report forms also included a numerical rating
scale to capture pain severity after each treatment.
Data collection
Baseline data collection consisted of a baseline question-
naire and two objective self-administered tests of pain
provocation to identify PGP [19]. Patient-reported out-
comes were assessed at 8 weeks follow-up, to maximise
the likelihood that most participants would have re-
ceived their full course of treatment but would not have
given birth. Non-responders to the 8-week follow-up
mailing received a reminder mailing 2 weeks later. At-
tempts to collect a minimum outcome dataset by tele-
phone occurred 2 weeks after the postal reminder.
Maternity records were reviewed following delivery to
collect maternal and neonatal outcomes. Data on adverse
events were collected on case report forms completed
after each physiotherapy treatment from self-report of
participants in the 8 weeks follow-up questionnaire and
through maternity record reviews.
Outcomes
All outcomes were included to inform a future full trial.
No primary outcome was defined for this pilot trial, as
the feasibility of use of a number of key pain and disability
outcomes was investigated.
Process outcomes
These included recruitment rates, follow-up rates at
8 weeks, attendance at treatment sessions, treatment
protocol adherence and completion rates on key out-
come measures, as well as floor and ceiling effects of key
outcomes measures.
Table 1 Acupuncture points and depth of needling in the true
acupuncture arm
Point Description Depth of insertion/needle
Local points
BL23 1.5 cun lateral to the spinous
process of L2
30–40 mm/50 mm
BL24 1.5 cun lateral to the spinous
process of L3
30–40 mm/50 mm
BL25 1.5 cun lateral to the spinous
process of L4
30–40 mm/50 mm
BL26 1.5 cun lateral to the spinous
process of L5
30–40 mm/50 mm
BL27 1.5 cun lateral to the spinous
process of S1
30–40 mm/50 mm
BL28 1.5 cun lateral to the spinous
process of S2
20–30 mm/40 mm
BL54 3 cun lateral to the spinous
process of S4
50–70 mm/75 mm
BL31 Over the first sacral foramen 20–30 mm/40 mm
BL32 Over the second sacral foramen 20–30 mm/40 mm
BL33 Over the third sacral foramen 20–30 mm/40 mm
GB30 Over the piriformis muscle,
at junction of lateral 1/3 and
medial 2/3 of line joining sacral
hiatus and greater trochanter
of the femur
50–70 mm/75 mm
HJJ L4 One fingerbreadth lateral to the
spinous process of L4
30–40 mm/50 mm
HJJL5 One fingerbreadth lateral to the
spinous process of L5
30–40 mm/50 mm
All of the above points can be needled bilaterally. Tender points over
the gluteus minimus and the pelvic rim can also be included.
Distal points
GB34 One fingerbreadth anterior
and one inferior to the
fibular head
25–30 mm/40 mm
ST36 3 cun below the joint line of
the knee and a fingerbreadth
lateral to the tibial crest
25–30 mm/40 mm
LR3 Just distal to the junction of
the bases of the first and
second metatarsal bones
25–30 mm/40 mm
LI4 On the highest point of the
first dorsal interosseous muscle
of the hand
20–30 mm/40 mm–30 mm
BL60 Midway between the lateral
malleolus and the
Achilles tendon
15–25 mm/30 mm
BL62 1 cun below the tip of the
lateral malleolus
10–20 mm/30 mm
One or two of the above points are to be included in the treatment.
Not necessary to needle bilaterally, unless the clinician judges it to
be needed.
The acupuncture protocol was informed by acupuncture texts, a national survey of
acupuncture practice (Bishop et al. 2015) and previous studies (Elden et al. 2008 [18])
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Clinical outcomes
These included measures of pain, everyday function and
general health at 8-week follow-up as well as the overall
global rating of change since baseline, whether or not
the woman was still pregnant (and if yes, number of
weeks gestation), treatment credibility, satisfaction with
the treatment package received, satisfaction with the re-
sults from treatment and side effects experienced.
Economic outcomes
Patient-level data on costs were collected to conduct a
preliminary economic evaluation and inform the design
of a cost-utility analysis alongside a future full trial. NHS
resource use data included GP consultations, number of
treatment sessions attended by each participant, visits to
other health care professionals, outpatient appointments,
investigations or treatments and inpatient stays related
to their back pain during pregnancy. To assess broader so-
cietal economic consequences, self-reported data on em-
ployment status, occupation, time off work and reduced
productivity at work (presenteeism) were collected over
the 8 weeks study period. Patient borne costs were over
the counter medicines and devices and costs associated
with attending trial treatment sessions, namely travel
costs, time off work and child care costs. Quality of life
was assessed through the EQ-5D-5L questionnaire [20].
Maternal/neonatal outcomes
These were collected from maternity records for all par-
ticipants and included gestational week at time of birth,
live births, length of labour (and second stage of labour),
if labour was induced, mode of birth, whether the
woman had an episiotomy or a perineal tear, estimated
blood loss at birth, antenatal and postnatal haemoglobin
count, pain relief during labour, baby’s gender, birth
weight, Apgar scores at 1 and 5 min and whether the
baby was admitted to the neo-natal unit.
Adverse events
Data on adverse events (AEs) were collected through
case report forms completed after each physiotherapy
treatment, through self-report of participants in the 8-
week follow-up questionnaire and through maternity
record reviews. Expected AEs from the acupuncture
interventions include drowsiness/light headedness, nau-
sea/vomiting, fainting, bruising at needle sites, feeling
hot/burning, headaches and transient pain at needle
sites. We defined serious adverse events (SAEs) of
death, hospitalisation, significant disability or incapa-
city, any life-threatening circumstance (to the woman
or developing child) or any other medically significant
occurrences that were potentially attributable to the
trial procedures or treatments. SAEs were identified
via treating physiotherapists.
A summary of the outcomes is shown in Table 2.
Blinding
Women randomised to standard care plus either true or
non-penetrating acupuncture were blinded to which type
of acupuncture they received. Physiotherapists providing
the treatments could not be blinded but were not in-
volved in any data collection procedure. Staff dealing
with baseline and outcome data collection were blind to
the intervention allocation. In addition, analyses of patient-
reported outcomes at 8 weeks follow-up were conducted
and verified by blinded statisticians.
Statistical analysis
As a pilot trial, the analysis was mainly descriptive to in-
form the design of a full trial. A statistical analysis plan
was developed with and agreed by the Trial Steering
Committee prior to the start of analysis. All statistical
analysis was performed using Stata version 13 [21].
Descriptive statistics were used to summarise key
process and outcome variables. A CONSORT flowchart
[13] shows the flow of participants into the trial, num-
bers allocated to each treatment arm, those providing
follow-up data and included in the analysis. The success
of each recruitment method was assessed by summaris-
ing the number and proportion of participants identified
and recruited through each method. Description of par-
ticipant baseline characteristics allowed an assessment of
similarity between treatment arms. Descriptive summar-
ies of the treatments delivered by treatment arm were
described to assess treatment delivery and adherence to
the protocol. For evaluation of the physiotherapist training
programme, self-confidence in assessing and treating
women with pregnancy-related back pain and changes
in the reported management of a typical patient were
examined. Descriptive statistics were used to summarise
key clinical outcomes for those with data at both baseline
and follow-up for each treatment arm; the degree of
missing data was assessed in relation to all potential
outcome measures. To inform the possible choice of
primary outcome for a full trial, the performance of
two measures of physical function (the ODI and the
PGQ) and one measure of pain severity (a 0–10 numer-
ical rating scale) was considered. This included the
amount of missing data at the item and scale levels, any
evidence of floor or ceiling effects, the precision of the
outcome measures based on the standard error of
measurement and their responsiveness to change. A de-
tailed comparison of these measures will be reported in
a separate paper.
Additional information on obstetric birth/neonatal out-
comes for those women who reach the time of delivery
within the timescale of the trial, overall and by treatment
arm were described to assess any impact of treatment arm
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Table 2 EASE Back pilot trial outcome measures
Domains Description
Process outcomes Recruitment rates, follow-up rates at 8 weeks
(overall and in each treatment arm), attendance
at treatment sessions, treatment protocol adherence,
key outcome measure completion rates, floor and
ceiling effects of key outcomes measures
Maternity record data
Maternal outcomes Gestation week at delivery, live births, length of labour
(and second stage of labour), induction required,
mode of delivery, episiotomy or a perineal tear,
estimated blood loss at birth, antenatal and postnatal
haemoglobin count, pain relief during labour
Neonatal outcomes Gender, weight, Apgar score at 1 and 5 min, admittance
to neonatal unit
Questionnaire data Timepoint
Baseline 8 weeks full 8 weeks MDCa
Socio-demographics Age, education (highest qualification), marital status,
social support (living alone), number of children and
pregnancies, job title, physical demands of work,
overall work satisfaction, current body mass index (BMI)
and pre-pregnancy BMI
✓ ✗ ✗
Work performance Work status, time taken off work because of LBP,
performance at work
✓ ✓ ✗
Pain location Body chart (coded into LBP only, LBP with anterior PGP,
LBP with pain in other bodily regions, or LBP with
anterior PGP and pain in other bodily regions)
✓ ✗ ✗
Pain Duration of current episode ✓ ✗ ✗
Pain index (Dunn et al. 2010 [23]): mean of 3 numerical
rating scales (least, usual and current pain)
✓ ✓ ✓
Pain intensity before bed (Elden et al. 2008 [18]) ✓ ✓ ✗
Sleep Frequency of pain preventing sleep onset and
waking at night
✓ ✓ ✗
Impact of pain on daily activities Oswestry Disability Index (Fairbank et al. 1980 [24]) and
the Pelvic Girdle Questionnaire (Stuge et al. 2011 [25],
Grotle et al. 2012 [26])
✓ ✓ ✓
Quality of life EuroQol EQ-5D-5L (Herdman et al. 2011 [20]) and SF-12
(Ware et al. 1996 [27])
✓ ✓ ✗
Use of medication, treatments
or appliances
Over the counter and prescribed ✓ ✓ ✗
Treatment specific preferences
and expectations
Preference for EASE Back treatments, expectation of effect
of EASE Back treatments (11 point NRS no expected
change–full recovery)
✓ ✗ ✗
Global improvement Global rating of change since baseline—1 item 6 response
options (complete recovery–much worse)
✗ ✓ ✓
Pregnancy If still pregnant, if pregnant weeks gestation ✗ ✓ ✓
EASE Back treatment related
costs borne by participant
Time off work for appointments (paid, unpaid, self-employed),
how work was covered, time impact of treatment on other
activities (family/domestic responsibilities, leisure activities,
housework, studying), child care costs, accompanied to
appointments, mode of transport and transport costs
✗ ✓ ✗
Health care utilisation Consultations, investigations and treatments ✗ ✓ ✗
Treatment credibility Confidence treatment helped pain, confidence in recommending
treatment to others, perception of logic of treatment, perceived
usefulness of treatment for alleviating other complaints
✗ ✓ ✗
Bishop et al. Pilot and Feasibility Studies  (2016) 2:72 Page 7 of 19
allocation on gestation, obstetric or neonatal outcomes.
Satisfaction with treatment and assessment of treatment
credibility was described by treatment arm. Any AEs and
any SAEs considered to be related to the study procedures
or interventions were described.
Health economic evaluation
In the absence of standard practice regarding the type of
economic evaluation to conduct alongside feasibility and
pilot studies, a cost–consequence analysis was chosen,
with the aim of informing the design of a cost analysis
within a full trial. The SC+NPA arm of the trial was not
included in the economic analysis; therefore, key results
relate only to the costs and consequences for the SC and
SC+TA arms of the trial. Costs for each trial arm were
calculated for each broad cost category (health care
costs, patient-incurred costs, productivity costs) and in a
disaggregated form within each of these cost categories.
The base-case cost analysis adopted a National Health
Service (NHS) and personal social services (PSS) per-
spective. A broader costing perspective was considered
in a sensitivity analysis, taking into account NHS/PSS
costs, patients’ personal expenditure and costs associated
with work loss. Quality of life scores at baseline and
8 weeks and total QALYs over the 8-week period were
calculated using the EQ-5D 5L. Analyses were mainly
descriptive, and all costs and outcomes are summarised
using means and standard deviations. As part of the
sensitivity analysis, the results were replicated from a
healthcare and wider societal perspective.
Results
Of 388 women assessed for eligibility over the 27-week
recruitment period (April to October 2013), 108 did not
meet the eligibility criteria. Of the 280 who were poten-
tially eligible, 155 were either not assessed for full eligi-
bility or were eligible but declined to participate and 125
women (45%) were recruited and randomised. One par-
ticipant, in the SC+NPA arm, was randomised in error
(they fulfilled the exclusion criteria for a high risk
pregnancy) and was subsequently withdrawn prior to
treatment. Overall, the 8-week follow-up rate was 73%
(n = 91). Participant flow into the EASE Back pilot trial
is shown in the CONSORT diagram in Fig. 1.
Participants’ baseline characteristics
Participants’ baseline characteristics (Table 3) were largely
similar across the three treatment arms. The mean age of
the 124 participants who were randomised and completed
a baseline questionnaire was 28 (SD 5.3) years and 53
(43%) were 24 or more weeks pregnant at the time of in-
clusion. More than half (68/124) had their pain for more
than 6 weeks and the mean pain severity (Pain Index) was
4.6 (SD 1.7). About a third (36/124) had severe back pain-
related disability and just over a quarter (38/144) had LBP
and anterior PGP and pain in other parts of the body.
Recruitment and follow-up
Recruitment lasted for a total of 27 weeks from April to
October 2013. The number and proportion of women
identified and recruited through the six methods are
presented in Table 4. The brief screening questionnaire
for back pain given to women as they attended their
routine 20-week ultrasound scan appointment was the
most successful method, followed by community mid-
wives providing women with an EASE Back study card
and women self-referring following the local awareness-
raising efforts.
The 8-week follow-up rate was 73% (91/124). There
was a slight imbalance in the follow-up rates between
treatment arms with the SC plus non-penetrating acu-
puncture arm having the lowest response rate at 8 weeks
(66%) compared to 80 and 76% in the SC and SC plus
acupuncture arms, respectively. Only 14% of the women
had given birth by the time they returned the 8-week
follow-up questionnaire.
Blinding
During telephone minimum data collection (MDC), three
cases of unblinding of the research nurse conducting the
calls were recorded out of the 70 MDC calls conducted.
All three had been randomised to receive SC plus true
acupuncture.
Treatment delivery and adherence
Descriptive summaries of the treatments delivered are
shown in Table 5. Only 4 of the 41 participants (10%)
randomised to SC accessed face-to-face physiotherapy.
Eight participants randomised to SC+TA, and three in
Table 2 EASE Back pilot trial outcome measures (Continued)
Patient satisfaction Satisfaction with EASE Back treatment package received,
satisfaction with results of treatment
✗ ✓ ✗
Perceived side effects
of treatment
Any side effects due to treatment and checklist of symptoms ✗ ✓ ✓
Objective tests
Self-administered objective
tests
Participant generated thigh thrust (P4) and bridging test with
leg extension (Olsen et al. 2009 [19])
✓ ✗ ✗
MDC is minimum data collection where only key outcomes were collected from non-responders
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the SC+NPA arm failed to attend for any treatment and
therefore received no acupuncture. The number of treat-
ments participants received was lower than anticipated,
mainly due to the high levels of non-attendance for
treatment appointments. Whilst the average number of
treatment sessions in both arms receiving acupuncture
was 6 (in line with the specified protocols), 13 (38%) in
the SC+TA arm and 9 (23.7%) in the SC+NPA arm
attended for fewer than 6 sessions.
Physiotherapy training programme and experience of
delivering trial treatments
The training programme for participating physiothera-
pists increased their self-confidence in assessing and
managing women with pregnancy-related LBP. Median
self-confidence pre-training (measured on a 0–20 scale)
was 8.0 (IQR 6.0, 11.0) and after training was 16.0
(IQR 16.0, 17.0) which was unchanged at the end of
the trial.
For treatment of the typical patient presented in the
vignette, increase in the reported use of written advice
on self-management, advice to continue with everyday
activities, advice about safe pharmacological treatment
options and advice about the use of home massage were
seen following the EASE Back training programme.
Supervised exercise, strengthening exercise, pelvic floor
exercise and acupuncture all increased following the
training programme.
In the feedback workshop, physiotherapists made the
following recommendations for a full trial:
 adding uncontrolled epilepsy, allergy to metal and
allergy to latex (constituent of the elasticated
bandage used as pelvic support) to the list of
exclusion criteria for a future full RCT
 adding extra emphasis that participation in the trial
meant attending for a full course of treatment
sessions as arranging suitable appointments and
non-attendance rates were problematic
Fig. 1 CONSORT diagram for the EASE Back pilot trial
Bishop et al. Pilot and Feasibility Studies  (2016) 2:72 Page 9 of 19
Table 3 Baseline characteristics of pilot trial participants
Baseline characteristics Standard care SC + true acupuncture SC + non-penetrating
acupuncture
(n = 41) (n = 42) (n = 41)
Age (years), mean (SD) 27.8 (5.4) 28.1 (5.1) 29.0 (5.3)
Highest qualification: degree/postgraduate, n (%) 13 (31.7) 14 (33.3) 18 (43.9)
Gestation weeks at inclusion: 24+, n (%) 17 (41.5) 18 (42.9) 18 (42.9)
Married, n (%) 16 (39.0) 19 (45.2) 19 (46.3)
No. of children, n (%)
0 16 (39.0) 20 (47.6) 14 (34.2)
1 17 (41.5) 13 (31.0) 17 (41.5)
2 or more 8 (19.5) 9 (21.4) 10 (24.4)
Working, n (%) 28 (68.3) 27 (64.3) 32 (78.1)
Physical demands of current/most recent paid job:
heavy/very heavy, n (%)
12 (29.3) 13 (32.5) 11 (26.8)
Taken time off during the current pregnancy because
of back paina, n (%)
8 (28.6) 9 (33.3) 15 (46.9)
Back pain interference with performance at work
(0–10 NRS) a, b, mean (SD)
5.0 (2.5) 4.9 (2.6) 5.0 (3.1)
Work satisfaction (0–10 NRS)a, c, mean (SD) 6.6 (2.7) 5.4 (1.9) 6.6 (2.3)
Pain location (manikin), n (%)
Low back pain only 7 (17.1) 9 (21.4) 7 (17.1)
Low back pain with anterior PGP 8 (19.5) 6 (14.3) 4 (9.8)
LBP with anterior PGP and pain elsewhere 10 (24.4) 14 (33.3) 12 (29.3)
LBP and pain elsewhere 16 (39.0) 13 (31.0) 18 (43.9)
Duration of episode: >6 weeks, n (%) 23 (56.1) 20 (47.2) 25 (61.0)
Pain indexd, mean (SD) 4.5 (1.6) 4.5 (1.5) 4.6 (1.8)
Pain intensity before going to bed, mean (SD) 6.8 (1.9) 6.8 (1.8) 7.0 (2.2)
Woken up most/every night by pain, n (%) 16 (39.0) 15 (35.7) 17 (41.5)
Oswestry Disability Index (0–100)e, mean (SD) 34.8 (11.2) 32.9 (13.7) 35.7 (13.6)
Oswestry Disability Index (categorised), n (%)
Minimal disability (0–20%) 5 (12.2) 8 (19.0) 4 (9.8)
Moderate disability (21–40%) 24 (58.5) 20 (47.6) 23 (56.1)
Severe disability (40–60%) 12 (29.3) 13 (31.0) 11 (26.8)
Crippledf (61–80%) 0 (0.0) 1 (2.4) 3 (7.3)
Pelvic Girdle Questionnaire (0–100)g, mean (SD)
Total 56.9 (16.0) 48.7 (17.2) 54.2 (17.3)
Activity subscale 54.6 (17.0) 46.7 (18.1) 52.7 (18.1)
Symptom subscale 65.4 (17.1) 56.1 (17.2) 59.3 (19.9)
Pre-pregnancy BMI, n (%)
Normal/underweight 16 (40.0) 19 (47.5) 12 (31.6)
Overweight 8 (20.0) 11 (27.5) 17 (44.7)
Obese/morbidly obese 16 (40.0) 10 (25.0) 9 (23.7)
Taking prescribed medication, n (%) 7 (17.1) 5 (11.9) 5 (12.2)
Treatment preferences: Yes, n (%) 10 (24.4) 8 (19.1) 10 (24.4)
SF12—PCS, mean (SD) 36.4 (7.6) 38.2 (8.0) 37.0 (9.7)
SF12—MCS, mean (SD) 46.6 (10.1) 44.7 (12.1) 48.1 (11.7)
Bishop et al. Pilot and Feasibility Studies  (2016) 2:72 Page 10 of 19
 including more content on management of pubic
symphysis pain (anterior PGP) in the
physiotherapists’ training programme.
The participating physiotherapists reported that the fol-
lowing aspects worked well in the pilot and should be in-
cluded in a future full RCT: the offer of evening treatment
times to participants; scheduling participants’ whole treat-
ment course into physiotherapists’ diaries; ensuring flexi-
bility in staff providing EASE Back treatments to cover
holidays; a minimum of two physiotherapists’ trained in
EASE Back at each treatment site to provide peer support
and sufficient capacity to treat participants; the mentoring
support and supervision from the acupuncture trainer;
and 1 hour new patient appointment slots to ensure there
was sufficient time to provide advice, start the exercise
programme and deliver acupuncture.
Missing data on key clinical outcomes, evidence of floor
or ceiling effect and responsiveness
There were no missing data for pain severity at both
baseline and follow-up for those who returned the ques-
tionnaires, but there were minimal amounts of missing
data for both ODI and PGQ. The proportion of the
questionnaire items with missing data for all participants
at baseline was 2.8 and 6.2% for the ODI and PGQ, re-
spectively. At follow-up, the proportion was 7.8 and
8.7% for the ODI and PGQ, respectively. No floor or
ceiling effects were shown in the total score of either the
ODI or the PGQ. All the instruments showed good re-
sponsiveness, with all the area under a receiver operating
characteristic curve more than 0.7. The detailed testing
of these measures is reported separately.
Exploratory analysis of key clinical outcomes
The descriptive statistics (mean and SD) of the key clini-
cal outcomes (pain and disability outcomes) at baseline
and 8 weeks follow-up are presented in Table 6. Table 6
also shows the differences in the mean scores from base-
line. Overall, there was a reduction in pain and disability
scores from baseline to 8 weeks follow-up. Greater re-
duction was observed in the SC+TA and SC+NPA arms
compared to SC alone.
The mean scores (with 95% CI) at 8 weeks follow-
up for each treatment arm adjusted for baseline
scores and other baseline covariates are shown in
Table 7. After adjusting for the baseline covariates, the
mean outcome scores at 8 weeks follow-up were higher
(worse outcome) in the SC arm compared to the true and
non-penetrating acupuncture arms suggesting the inter-
vention effects are feasible and worthwhile to pursue in a
main trial.
Obstetric birth/neonatal outcomes
All women who participated in the pilot trial had live
births (mean gestation 40 weeks (SD 1.5)). Labour dur-
ation was similar across treatment arms, as was the need
to be induced, the mode of delivery, the proportion of
women who either had an episiotomy or a perineal tear,
and the mean estimated blood loss at birth. Pain relief
used during labour was the same across all three treat-
ment arms. Neonatal outcomes were also very similar
across all three treatment arms. In total, only three ba-
bies (2.5%) were admitted to the neo-natal unit and 95%
or more of all babies had an Apgar score of 7–10 5 min
after birth.
Treatment credibility and satisfaction with care
Overall, about 60% (43/71) of participants who com-
pleted full follow-up questionnaire were either very or
quite confident that the information or treatment they
received helped their LBP problem, 3/24 (13%), 22/27
(82%), and 18/22 (86%) in the SC, SC+TA and SC+NPA
arms, respectively. In total, 69% (49/71) reported they
would be very or quite confident to recommend the in-
formation/treatment to a friend who suffered from a
Table 3 Baseline characteristics of pilot trial participants (Continued)
Self-assessed P4 test: familiar pain produced or increased
in lumbosacro-iliac areah, n (%)
25 (75.8) 26 (81.3) 22 (66.7)
Bridging with extension of leg: familiar pain produced
or increased in lumbosacro-iliac areah, n (%)
25 (89.3) 24 (80) 23 (82.1)
Positive on both P4 test and bridging test, n (%) 17 (41.5) 21 (50.0) 16 (39.0)
SF12-PCS Physical Component Scale, SF12-MCS SF12 Mental Component Scale (scales are based on a ‘normalised’ general population average of 50 with standard
deviation of 10)
aApplies to only those in paid job
bHigher mean score implies more interference
cHigher mean scores imply more satisfaction
dMean of three numerical rating scale for least, usual and current pain
eOswestry Disability Index has ten sections with scores ranging from 0 to 5 in each section, item scores are summed and transformed to yield a score of 0 to 100
where 100 is the worst possible score
f‘Crippled’ is the term used in the original classification of the Oswestry Disability Questionnaire
gPelvic Girdle Questionnaire—items are scored on a four-point scale, and item scores are summed and transformed to yield a score of 0 to 100 where 100 is the
worst possible score
hPercentage applies to those who were able to perform the test
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Table 4 Summary of the success of the six methods of identification and recruitment
1. Research midwives in usual
antenatal clinics
2. Screening questionnaire
at 20-week scan
3. Screening of women’s
health physiotherapy referrals
4. Research midwives or
obstetricians give women
EASE Back card
5. Community midwives
or GPs give women EASE
Back card
6. Self-referral Total
Total number of women
identified n (%)
28 (7.2) 199 (51.3) 49 (12.6) 3 (0.8) 73 (18.8) 36 (9.3) 388
Potentially eligible n 19 157 29 2 52 21 280
Randomised n (% of total
women identified)
12 (42.9) 48 (24.1) 8 (16.3) 2 (66.7) 39 (53.4) 16 (44.4) 125 (32.2)
Randomised n (% of
potentially eligible)
12 (63.2) 48 (30.6) 8 (27.6) 2 (100.0) 39 (75.0) 16 (76.2) 125 (44.6)
Column headings are the six methods of identifying and recruiting women
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Table 5 Summary of treatments delivered
Treatment arm
Standard care
(n = 41)
SC + true acupuncture
(n = 42)
SC + non-penetrating
acupuncture (n = 41)
Participants
Number of participants who booked appointment to see a physiotherapist 4 37 41
Total number of participants who attended at least one treatment
session with a physiotherapist
4 34 38
Total number of participants who received acupuncture treatment 0 33 36
Number of treatment sessions provided
(per participant), median (IQR)
2 (1, 4) 6 (3, 7) 6 (6, 7)
Number of treatment sessions per participant (categorised),
n (% of no. of participants seen)
1–5 4 (100) 13 (38.2) 9 (23.7)
6–8 0 (0.0) 17 (50.0) 27 (71.1)
9–11 0 (0.0) 4 (11.8) 2 (5.3)
Number of treatments per participant in line with protocolsa, n (% of number of
participants who attended at least one treatment session)
2 (50.0) 17 (50.4) 27 (71.1)
Treatment sessions: total number planned 13 240 273
Total number of treatment sessions provided (% of total planned) 9 (69.2) 189 (78.8) 224 (82.1)
Total number of sessions that were not attended—DNAs/UTAs
(% of total planned)
4 (30.8) 51 (21.3) 49 (17.9)
Total number of sessions attended where acupuncture
was provided, n (% of attended)
0 (0.0) 163 (86.2) 197 (87.9)
Pain severity after treatment (0–10), mean (SD) 6.0 (0.8) 1.9 (2.0) 2.3 (2.3)
Number (%) of participants who received the treatment at least
once during the course of treatment for participants who attended
at least one treatment session with a physiotherapist
n = 4 n = 34 n = 38
Assessment/reassessment 4 (100.0) 34 (100.0) 38 (100.0)
Education and advice 4 (100.0) 34 (100.0) 38 (100.0)
Tubigrip provided with instruction 3 (75.0) 17 (50.0) (50.0) 19 (50.0)
Pelvic support belt provided with instruction 2 (50.0) 9 (26.5) 7 (18.4)
Heat therapy used in clinic 0 (0.0) 3 (8.8) 2 (5.3)
Massage therapy used in clinic 0 (0.0) 8 (23.5) 8 (21.05)
Manual therapy used in clinic 0 (0.0) 0 (0.0) 2 (5.3)
Supervised exercises in clinic 1 (25.0) 24 (70.6) 20 (52.6)
Home exercises given/reviewed 4 (100.0) 29 (85.3) 33 (86.8)
Issued walking aids 2 (50.0) 2 (5.9) 5 (13.2)
Number (%) of participants offered an exercise approach at least
once during the course of treatment for participants who
attended at least one treatment session with a physiotherapist
n = 4 n = 34 n = 38
Transversus abdominus muscle strengthening 2 (50.0) 24 (70.6) 25 (65.8)
Pelvic floor muscle strengthening 2 (50.0) 19 (55.9) 21 (55.3)
Pelvic tilt exercise 3 (75.0) 26 (76.5) 21 (55.3)
Gluteal muscle strengthening 2 (50.0) 25 (73.5) 22 (57.9)
Lower back/pelvic stretching 1 (25.0) 15 (44.1) 10 (26.3)
Advice/signposting to general physical activity opportunities 2 (50.0) 8 (23.5) 12 (31.6)
Other exercisesb 1 (25.0) 13 (38.2) 15 (39.5)
DNA did not attend, UTA unable to attend, SC standard care, TA true acupuncture, NPA non-penetrating acupuncture
a2 to 4 sessions for SC, 6 to 8 for SC + acupuncture
bOther exercises included advice on aquanatal classes, increase repetitions, correcting standing posture, gym ball exercise, thoracic rotation, lumbar spine
extension, obliques exercises and reviewing exercises in the EASE Back booklet
Bishop et al. Pilot and Feasibility Studies  (2016) 2:72 Page 13 of 19
Table 6 Descriptive analysis of key clinical outcomes for those with data at both baseline and follow-up (n = 91)
Key outcomes Baseline 8 weeks follow-up Difference in mean score (or %) from baseline (baseline–8 weeks score) (95% CI)
Treatment arms Treatment arms
SC SC+TA SC+NPA SC SC+TA SC+NPA SC (n = 32) SC+TA (n = 32) SC+NPA (n = 27)
ODI score (0–100), mean (SD) 34.1 (11.4) 29.1 (10.9) 33.9 (13.6) 32.2 (18.8) 21.3 (17.7) 26.2 (14.4) 1.9 (−5.1, 8.8) 7.8 (1.6, 14.0) 7.7 (2.9, 12.5)
PGQ (0–100), mean (SD)
Total 57.3 (16.0) 45.9 (16.5) 51.9 (17.6) 52.2 (28.4) 31.9 (21.8) 40.3 (21.8) 5.1 (−5.1, 15.2) 14.0 (6.9, 21.2) 11.6 (5.2, 18.0)
Activity subscale 55.6 (16.9) 44.1 (17.6) 50.2 (18.9) 51.5 (29.4) 31.3 (22.1) 40.0 (23.4) 4.1 (−6.4, 14.6) 12.8 (5.4, 20.3) 10.1 (3.5, 16.8)
Symptom subscale 63.0 (16.8) 52.6 (16.4) 58.0 (19.6) 54.4 (26.5) 33.8 (22.4) 40.2 (20.2) 8.6 (−1.9, 19.0) 18.8 (11.1, 26.5) 17.8 (9.7, 25.8)
Pain indexa 4.4 (1.6) 4.3 (1.5) 4.2 (1.9) 4.2 (2.2) 2.4 (2.2) 2.2 (1.5) 0.2 (−0.8, 1.2) 1.8 (1.1, 2.5) 2.1 (1.4, 2.9)
Pain intensity before going to bed: 0–10 NRS,
mean (SD)
6.5 (2.1) 6.5 (2.1) 6.7 (2.2) 6.5 (2.8) 3.7 (2.8) 3.5 (2.3) 0.04 (−1.5, 1.6) 2.7 (1.4, 4.0) 3.2 (1.8, 4.5)
Woken up most/every night by LBP, n (%)c 9 (37.5) 6 (22.2) 7 (31.8) 9 (37.5) 4 (14.8) 1 (4.6) 0.0 (−27.4, 27.4) 7.4 (−13.2, 28.0) 27.3 (6.0, 48.6)
SF12-PCS, mean (SD) 36.2 (8.5) 38.7 (7.5) 37.6 (9.6) 36.5 (10.6) 41.4 (11.5) 43.3 (9.5) −0.3 (−5.5, 4.9) −2.8 (−6.2, 0.6) −5.7 (−10.7, −0.7)
SF12-MCSb, mean (SD) 49.1 (8.8) 47.7 (12.7) 51.4 (10.3) 49.1 (8.1) 48.4 (13.8) 50.2 (12.3) 0.03 (−4.1, 4.1) −0.2 (−4.2, 3.9) 1.2 (−5.3, 7.7)
ODI Oswestry Disability Index, PGQ Pelvic Girdle Questionnaire, SF12-PCS Physical Component Scale, SF12-MCS Mental Component Scale (scales are based on a ‘normalised’ general population average of 50 with
standard deviation of 10)
aMean of three numerical rating scale for least, usual and current pain
bHigher scores indicate better quality of life so negative sign in the difference indicate improvement in quality of life
cDifferences are percentages of those who reported waking up at night at baseline and at follow-up
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similar problem; however, the proportions rating treat-
ment credibility as high were much lower in the SC
alone arm (7/24 = 29%). Levels of satisfaction with the
treatment package received and the results from treat-
ment were high overall (65%) but lower in the SC arm
(17%) compared to SC+TA (85%) and SC+NPA (96%).
Health economic evaluation
Complete baseline and 8 weeks economic data were
available for 73 participants (24 in SC, 27 in SC+TA and
22 in SC+NPA); this represented 59% of the sample. The
analysis focused on the 51 participants receiving SC ver-
sus SC+TA, which informed the base-case analysis.
Table 8 shows the disaggregated mean (SD) costs for
each treatment arm. The cost of treatment was reported
as part of the total cost of each trial arm. The principle
aim of the cost-consequence analysis was to look at all the
costs of the two interventions (SC alone versus SC+TA)
and compare these with the corresponding outcomes in
terms of QALYs gain.
Table 9 shows the EQ-5D scores at baseline and
8 weeks and the total QALYs in the two arms. Health-
related quality of life increased at 8 weeks follow-up. At
8 weeks, we observed a lower EQ-5D score in partici-
pants in the SC arm and a higher score for the SC plus
true acupuncture arm.
The results show that although the SC+TA interven-
tion has the highest total NHS cost and health care costs
compared to SC alone, it is the intervention that also
achieves higher QALY gains. From an NHS/PSS perspec-
tive, the mean costs per woman were £215 for SC+TA
Table 8 Mean per participant costs by treatment arm over
8 weeks
Complete-case analysis SC SC+TA
n = 24
Mean £ (SD)
n = 27
Mean £ (SD)
Intervention in the trial 11.52 (43.2) 149.43 (71.14)
GP visit(s) 12.75 (29.8) 17.62 (39.3)
NHS midwife 6.25 (30.6) 16.66 (48.03)
Private midwife 0.00 (−) 3.55 (18.4)
NHS acupuncture 0.00 (−) 9.96 (51.76)
NHS physiotherapist 2.04 (10.0) 16.85 (69.2)
‘Other’ professionals in NHS 5.83 (28.6) 3.74 (19.43)
Prescriptions 1.76 (8.6) 0.54 (2.8)
‘Over the counter’ treatments 8.67 (14.3) 7.38 (21.7)
LBP related work absencea 98.36 (330.3) 258.86 (517.8)
LBP related reduced productivity 806.55 (769.58) 783.45 (762.7)
NHS/PSS cost 40.15 (90.78) 214.82 (191.92)
Incorporation of back pain-related healthcare resource use (n = 51)
Healthcare cost, £b 48.82 (94.18) 225.77 (205.65)
Incorporation of back pain-related wider societal resource use (n = 51)
Societal cost, £c 953.74 (921.14) 1268.08 (1207.24)
Values are mean (sd) number of consultations/investigations unless
stated otherwise.
SC standard care, SC+TA standard care plus true acupuncture
aIncludes both work absence due to LBP and work absence to attend
treatment sessions
bIncludes costs to the NHS, private health care costs and over-the-counter
medication costs
cIncludes healthcare costs and productivity related costs
Table 9 EQ-5D scores by treatment arm (mean and SD)
Complete-case analysis SC SC+TA
Baseline n = 41 n = 42
0.649 (0.12) 0.651 (0.16)
8 weeks n = 24 n = 27
0.570 (0.23) 0.698 (0.22)
Total QALYs 0.096 (0.02) 0.106 (0.02)
Adjusteda 0.096 0.106
SC standard care, SC+TA standard care + true acupuncture
aIncremental QALY estimates following multiple regression-based adjustment
for baseline scores on the EQ-5D
Table 7 Adjusted estimates (estimated marginal means and 95% CI) of key outcomes at 8 weeks follow-up for each treatment
arm separately
Key outcomes Outcome mean (95% CI) adjusted for baseline
scores only
Outcome mean (95% CI) adjusted for baseline scores
and other covariatesd
Treatment arms Treatment arms
SC SC+TA SC+NPA SC SC+TA SC+NPA
ODI scorea (0–100) 31.2 (25.5, 36.9) 23.2 (17.5, 28.8) 25.2 (19.1, 31.3) 31.3 (25.5, 37.0) 23.3 (17.5, 29.0) 25.0 (18.8, 31.3)
PGQb (0–100)
Total 48.3 (40.5, 56.2) 35.8 (28.0, 43.5) 40.1 (31.8, 48.3) 48.3 (40.5, 56.1) 36.7 (29.0, 44.4) 40.0 (30.7, 47.2)
Activity subscale 47.6 (39.5, 55.7) 35.3 (27.3, 43.2) 39.9 (31.4, 48.4) 47.7 (39.7, 55.7) 36.2 (28.3, 44.2) 38.6 (30.1, 47.1)
Symptom subscale 52.0 (44.1, 60.0) 36.2 (28.3, 44.0) 40.1 (31.7, 48.5) 52.4 (44.4, 60.3) 36.0 (28.1, 43.8) 40.0 (31.5, 48.4)
Pain severity (pain index)c 4.1 (3.4, 4.8) 2.5 (1.8, 3.2) 2.1 (1.4, 2.9) 4.1 (3.4, 4.7) 2.6 (1.9, 3.2) 2.1 (1.3, 2.8)
aOswestry Disability Index scores range from 0 to 100 with higher scores indicating greater disability
bPelvic Girdle Questionnaire scores range from 0 to 100 where 100 is the worst possible
cMean of three numerical rating scale for least, usual and current pain score
dAdjusted for baseline outcome score, age, gestation week and baseline pain severity (for the disability outcomes) and ODI score for the pain severity outcome
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and £40 for SC alone. These costs reflect the higher re-
source use attributable to the additional acupuncture
sessions and the relatively small reported increase in
utilisation of acupuncture, midwifery and physiotherapy
in a few participants in that treatment arm. Therefore,
acupuncture provided in addition to SC seems more
effective in treating pregnant women with LBP, but this
increased effectiveness comes at an increased cost.
Adverse events
No serious adverse events (SAEs) attributable to the trial
interventions or trial processes were reported. There
were four potential SAEs reported by treating physio-
therapists to the trial team (one in SC, two in SC+TA
and one in SC+NPA); all were brief periods of hospital-
isation or admission to the maternity assessment unit,
for reasons other than those related to the trial or treat-
ments. All women were discharged after brief monitor-
ing and all resumed treatment.
Minor adverse reactions
Minor adverse reactions were reported by physiothera-
pists on case report forms. All were expected minor ad-
verse events, with the most common slight bleeding at
the needle sites in 35 (21%) treatment sessions in the SC
plus true acupuncture arms and in 1 (0.5%) treatment
session in the SC plus non-penetrating acupuncture
arm. Other expected minor adverse events which in-
cluded pain on needle insertion, slight bruising, drowsi-
ness and slight soreness which occurred in less than 4%
of treatment sessions.
Discussion
This pilot trial has shown that a future full RCT is feasible.
The eligibility criteria, patient information, processes for
consent and randomisation, treatment protocols and case
report forms worked well in the pilot RCT and should be
included in a future full trial.
Key findings and design implications for a full trial
Identification and recruitment of women
We identified women using six methods, three of
which were the most successful and should be used
in a full trial. These were the brief screening ques-
tionnaire given to women as they attended their
routine 20-week ultrasound scan appointment, com-
munity midwives providing women with an EASE
Back study card and women self-referring to the
trial team following local awareness-raising efforts.
We recruited a greater than anticipated proportion
(45%) of eligible women, bearing in mind the young
age group, many of whom were working and had
other children to care for. In addition, the upper limit of
31 weeks gestation resulted in only 14% of participants
giving birth prior to 8 weeks follow-up meaning improve-
ments could be attributed to the interventions rather than
being driven by improvements once women have given
birth.
Training of physiotherapists
We trained 14 physiotherapists to deliver the EASE Back
interventions and provided mentoring support. Training
of physiotherapists will be important in a full trial as
although all the participating physiotherapists had com-
pleted national standards of training in acupuncture,
none were using it to manage women with pregnancy-
related LBP prior to the pilot RCT training. This reflected
our previous findings during the development of this pilot
RCT that highlighted physiotherapists lack of experience
of using acupuncture with pregnant women and concerns
about safety [11]. The questionnaires completed by the
physiotherapists showed marked increases in their self-
confidence in assessing and managing pregnancy-related
LBP and increased use of recommended management ap-
proaches such as providing written information, advice on
safe pharmacological options and strengthening and pelvic
floor exercises with more supervision of exercise by the
physiotherapist.
Interventions
Treatments were delivered broadly in line with specified
protocols, although some women did not attend for their
allocated treatments despite efforts to contact them and
re-engage them in treatments. A choice of appointments
for treatment was provided, including different treat-
ment centres and day and evening appointments, and
this level of flexibility will be essential in a full trial. In
the acupuncture arms, additional treatment consisted
mostly of education, advice and exercises, particularly
strengthening and pelvic floor exercises. Small numbers
of participants received pelvic supports, heat and mas-
sage. These additional treatments were in line with the
protocol. Very few women in the SC only arm accessed
face-to-face physiotherapy (4 of 41) even though this
was an option in the protocol. The reasons for this are
unclear and this could be further investigated in a full
trial using qualitative methods.
Follow-up
The follow-up rate in the pilot trial was 73% at 8 weeks,
slightly less than we had hoped. However, we did antici-
pate this, as we were asked to remove one follow-up re-
minder from our usual trial follow-up processes by the
research ethics committee and whilst we appealed this,
the request was upheld. If we used our usual trial follow-
up procedure which would include a further reminder
mailing and telephone follow-up of non-responders, a
minimum of 80% follow-up is likely to be achieved.
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However, a longer reminder and follow-up period would
likely result in a greater proportion of women having
given birth by the time they provided follow-up data.
Choice of primary outcome for a main trial
The pilot trial included two measures of physical func-
tion (the ODI and the PGQ) and one measure of pain
severity, to inform the choice of primary outcome for a
future main trial. Several factors were taken into consider-
ation in examining the performance of these measures.
These included the amount of missing data at the item
and scale levels; any evidence of floor or ceiling effects,
the precision of the outcome measures based on the
standard error of measurement and their responsiveness
to change. The detailed testing of these measures is re-
ported separately, but taking all aspects of the perform-
ance of the measures into account, the PGQ is the
recommended primary outcome for a future main RCT.
Sample size for a full trial
A future full trial is likely to be best powered to detect
moderate differences between SC versus SC plus true
acupuncture (testing effectiveness). If a future full trial
also includes a comparison between SC plus true acu-
puncture versus SC plus non-penetrating acupuncture
(testing the added efficacy of needle penetration and
manipulation) or a treatment course of exercise-based
physiotherapy (providing an attention control and test-
ing the added efficacy of acupuncture), we anticipate
needing to power the trial to detect small differences
between these interventions. Using the PGQ total score
at 8 weeks follow-up as the primary outcome of a fu-
ture main trial, analysis of covariance (ANCOVA) with
baseline covariate adjustment (baseline PGQ total score,
gestation week, age) as the main analysis, with the covari-
ates having a combined R-squared of 0.5 with the re-
sponse, 80% power and 5% two-tailed significance level,
we estimate that approximately 200 participants per trial
arm would be needed to detect a four-point difference
between true and non-penetrating acupuncture arms,
using a baseline SD of 18 and allowing for 20% loss to
follow-up. Thus, a future two-arm trial would require ap-
proximately 400 participants and three-arm trial would re-
quire 600 participants. The standard deviation for the
sample size calculation was derived from the pilot data
but allowing for the uncertainty surrounding the pilot
estimates (i.e. using an 80% upper one-sided confidence
limit) [22].
We also tested ways to collect health economic data
and conducted an exploratory health economic analysis.
As the cost-consequence results reported here are based
on a small sample size, a full trial would be required to
conduct a fully incremental analysis to make any recom-
mendations based on cost-effectiveness. One limitation
with the exploratory analysis is that although care was
taken to avoid double counting, some of the patients
could have reported visits as part of the trial within the
additional health care visits.
Strengths and limitations
This is the only randomised trial of acupuncture and
standard care for women with pregnancy-related back
pain in the UK. The strengths of this pilot trial were that
all the procedures to inform a full trial design were
tested, including identification of eligible participants,
recruitment, randomization, intervention delivery and
short-term follow-up. Only a short-term follow-up was
included in the pilot trial and so cannot inform the likely
response to a longer term outcome, which would be de-
sirable in a full trial. As discussed earlier, the 8-week
follow-up rate was less than 80%, but the number of
follow-up reminders we had originally planned to use
was reduced by the research ethics committee. Although
we are confident that an additional follow-up reminder
would achieve a higher follow-up rate, attention needs
to be given to follow-up procedures in a full trial. As
stated throughout the paper, this was a pilot trial and
was not powered for hypothesis testing of clinical and
cost outcomes. The clinical outcomes and cost results
should therefore be viewed as exploratory. Clinical and
cost-effectiveness can only be assessed in a full trial.
Conclusions
In conclusion, a future main RCT testing the additional
benefit of acupuncture to standard care is feasible. A full
RCT, with longer term follow-up, would provide evi-
dence about the effectiveness of acupuncture and inform
treatment choices for women with pregnancy-related
LBP.
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